Patents/Inventors

Bahram Valamehr

San Diego, CAUS21 patents

17 Patents

US126180492026
Reprogramming Methods and Cell Culture Platforms
FATE THERAPEUTICS, Inc.
0 cites
US124351232025
Immunotherapies Using Enhanced Ipsc Derived Effector Cells
FATE THERAPEUTICS, Inc.
0 cites
US124198702025
Compositions and Methods for Immune Cell Modulation in Adoptive Immunotherapies
Fate Therapeutics, Inc.
0 cites
US124159892025
Cell Culture Platform for Single Cell Sorting and Enhanced Reprogramming of Ipscs
Fate Therapeutics, Inc.
0 cites
US124104032025
Methods and Compositions for Inducing Hematopoietic Cell Differentiation
FATE THERAPEUTICS, Inc.
0 cites
US123983732025
Enhanced Immune Effector Cells and Use Thereof
FATE THERAPEUTICS, Inc.
0 cites
US123850122025
Methods and Compositions for Inducing Hematopoietic Cell Differentiation
Fate Therapeutics, Inc.
0 cites
US123518312025
Platform for the Induction and Maintenance of Ground State Pluripotency
Fate Therapeutics, Inc.
0 cites
US122813292025
Compositions and Methods for Immune Cell Modulation in Adoptive Immunotherapies
FATE THERAPEUTICS, Inc.
0 cites
US122759552025
Combining Ipsc Derived Effector Cell Types for Immunotherapy Use
FATE THERAPEUTICS, Inc.
0 cites
US122643222025
Minimal Volume Reprogramming of Mononuclear Cells
FATE THERAPEUTICS, Inc.
0 cites
US122472262025
Cellular Reprogramming Using Temporal and Transient Plasmid Vector Expression System
FATE THERAPEUTICS, Inc.
0 cites
US122030982025
Cells Having Solid Tumor Targeting Backbone and Use Thereof
FATE THERAPEUTICS, Inc.
0 cites
US121732742024
Enhanced Immune Effector Cells and Use Thereof
Fate Therapeutics, Inc.
0 cites
US121228462024
Chimeric Antigen Receptor for Tumor Targeting
ONO PHARMACEUTICAL CO., Ltd.
0 cites
US118516772023
Composition and Methods for Inducing Myeloid Suppressive Cells and Use Thereof
Fate Therapeutics, Inc.
0 cites
US116346882023
Methods and Compositions for Inducing Hematopoietic Cell Differentiation
Fate Therapeutics, Inc.
0 cites